Table 3.
MINORS tool for risk of bias
| Study | Clearly stated aim | Inclusion of consecutive patients | Prospective data collection | Endpoints appropriate to study aim | Unbiased assessment of study endpoint | Follow-up period appropriate to study aim | < 5% lost to follow-up | Prospective calculation of study size | Total |
|---|---|---|---|---|---|---|---|---|---|
| Satku et al. [9] | 2 | 0 | 1 | 2 | 1 | 2 | 2 | 0 | 10/16 |
| Verma and Mody [14] | 1 | 0 | 1 | 2 | 1 | 2 | 1 | 0 | 8/16 |
| Sharquie et al. [7] | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 0 | 11/16 |
| Madke et al. [6] | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 0 | 11/16 |
| Barbera et al. [10] | 2 | 0 | 1 | 2 | 1 | 2 | 2 | 0 | 10/16 |
| Pathania and Singh [13] | 2 | 0 | 1 | 2 | 1 | 2 | 2 | 0 | 10/16 |
| Mathur and Sharda [11] | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 0 | 11/16 |
| Nazeer et al. [12] | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 0 | 12/16 |